Filing Flows › CareDx (CDNA) › Q2 2026
CareDx (CDNA) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 30, 2026
CareDx (CDNA) reported revenue of $132M for the second quarter 2026 (Q2 2026), +52% from a year earlier and +12% from the quarter before. Operating margin was 85.8%, net earnings $111M (83.8% of revenue).
CareDx, Q2 2026: revenue $132M (+52% year over year), operating margin 85.8%, net earnings $111M, operating cash flow $30.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $132M | +12% | +52% |
| Operating profit | $113M | 95× | — |
| Net earnings | $111M | 39× | — |
| Operating cash flow | $30.6M | +606% | +209% |
| Free cash flow | $28.7M | 56× | +223% |
What changed
Revenue was $131.9M in Q2 2026, up 52% year over year and up 12% from the previous quarter. Testing services revenue was the largest line at 76% of revenue. Testing services revenue added $37.9M year over year (up 61%), 84% of the total change.
Operating profit was $113.2M, a 85.8% margin (up 98.6 points year over year). Total costs fell 81% while revenue rose 52%. Net earnings were $110.6M. The effective tax rate was 3.4%.
Operating cash flow was $30.6M (up 209% year over year), 28% of net earnings. Non-cash charges added back $2.8M of depreciation and amortization and $10.7M of share-based compensation. Working capital and other items used $93.5M. Capital expenditures of $1.9M left free cash flow of $28.7M.
Questions
What was CareDx's revenue in the second quarter 2026?
CareDx (CDNA) reported revenue of $132M for the second quarter 2026 (Q2 2026), +52% from a year earlier and +12% from the quarter before.
Was CareDx profitable in the second quarter 2026?
Operating profit was $113M (85.8% of revenue) and net earnings $111M.
Source: CareDx 10-Q on SEC EDGAR.